GERN
Geron Corp
Price:  
3.99 
USD
Volume:  
5,139,855.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

GERN EV/EBITDA

-234.2%
Upside

As of 2024-12-11, the EV/EBITDA ratio of Geron Corp (GERN) is -11.73. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. GERN's latest enterprise value is 2,435.45 mil USD. GERN's TTM EBITDA according to its financial statements is -207.60 mil USD. Dividing these 2 quantities gives us the above GERN EV/EBITDA ratio.

Note: valuation result may not be accurate due to the company's negative EBITDA.

Range Selected
Trailing P/E multiples 13.2x - 16.6x 15.0x
Forward P/E multiples 15.1x - 17.8x 15.9x
Fair Price (5.23) - (5.73) (5.35)
Upside -231.1% - -243.7% -234.2%
3.99 USD
Stock Price
(5.35) USD
Fair Price

GERN EV/EBITDA - Historical EV/EBITDA Data

Date EV/EBITDA
2024-12-09 -11.70
2024-12-06 -11.56
2024-12-05 -11.70
2024-12-04 -11.76
2024-12-03 -11.61
2024-12-02 -11.88
2024-11-29 -12.11
2024-11-27 -12.26
2024-11-26 -11.94
2024-11-25 -12.05
2024-11-22 -11.96
2024-11-21 -11.82
2024-11-20 -11.73
2024-11-19 -11.15
2024-11-18 -11.12
2024-11-15 -10.77
2024-11-14 -10.92
2024-11-13 -11.38
2024-11-12 -11.67
2024-11-11 -12.11
2024-11-08 -12.49
2024-11-07 -12.60
2024-11-06 -12.55
2024-11-05 -12.40
2024-11-04 -12.49
2024-11-01 -12.08
2024-10-31 -12.08
2024-10-30 -12.20
2024-10-29 -12.52
2024-10-28 -12.40
2024-10-25 -11.94
2024-10-24 -11.76
2024-10-23 -11.96
2024-10-22 -11.79
2024-10-21 -11.61
2024-10-18 -12.02
2024-10-17 -11.94
2024-10-16 -12.26
2024-10-15 -12.31
2024-10-14 -12.17
2024-10-11 -12.72
2024-10-10 -12.72
2024-10-09 -12.40
2024-10-08 -12.55
2024-10-07 -12.20
2024-10-04 -12.69
2024-10-03 -12.66
2024-10-02 -13.04
2024-10-01 -12.95
2024-09-30 -13.33